[Skip to Content]
[Skip to Content Landing]
Comment & Response
January 2017

Surgical Treatment for T4 Oropharyngeal Cancer

Author Affiliations
  • 1The University of Texas MD Anderson Cancer Center, Houston
JAMA Otolaryngol Head Neck Surg. 2017;143(1):96-97. doi:10.1001/jamaoto.2016.2242

To the Editor The article by Zenga et al1 on the role of surgery for T4 oropharyngeal cancer was interesting, but I believe it had several omissions that add to the limitations. The most problematic issue with the analysis was the inherent bias in a comparison between 2 groups, 1 that undergoes the therapy (surgery) and 1 that does not, when the latter group has patients who either medically or technically cannot receive the therapy.

×